{"id":"https://openalex.org/W2016275989","doi":"https://doi.org/10.1016/j.neuropharm.2004.08.019","title":"\u03b3-Hydroxybutyric acid (GHB) and \u03b3-aminobutyric acidB receptor (GABABR) binding sites are distinctive from one another: molecular evidence","display_name":"\u03b3-Hydroxybutyric acid (GHB) and \u03b3-aminobutyric acidB receptor (GABABR) binding sites are distinctive from one another: molecular evidence","publication_year":2004,"publication_date":"2004-11-03","ids":{"openalex":"https://openalex.org/W2016275989","doi":"https://doi.org/10.1016/j.neuropharm.2004.08.019","mag":"2016275989","pmid":"https://pubmed.ncbi.nlm.nih.gov/15567424"},"language":"en","primary_location":{"id":"doi:10.1016/j.neuropharm.2004.08.019","doi":"https://doi.org/10.1016/j.neuropharm.2004.08.019","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.neuropharm.2004.08.019","pdf_url":null,"source":{"id":"https://openalex.org/S160566677","display_name":"Neuropharmacology","issn_l":"0028-3908","issn":["0028-3908","1873-7064"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101948539","display_name":"Ying Wu","orcid":"https://orcid.org/0000-0002-7930-2399","observed_orcids":["https://orcid.org/0000-0002-7930-2399"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I2801317318","display_name":"Hospital for Sick Children","ror":"https://ror.org/057q4rt57","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801317318"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Ying Wu","raw_affiliation_strings":["Brain and Behavior Program, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada M5G 1X8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brain and Behavior Program, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada M5G 1X8","institution_ids":["https://openalex.org/I185261750","https://openalex.org/I2801317318"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021077846","display_name":"Saima Ali","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I2801317318","display_name":"Hospital for Sick Children","ror":"https://ror.org/057q4rt57","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801317318"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Saima Ali","raw_affiliation_strings":["Brain and Behavior Program, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada M5G 1X8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brain and Behavior Program, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada M5G 1X8","institution_ids":["https://openalex.org/I185261750","https://openalex.org/I2801317318"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110751699","display_name":"Gholamreza Ahmadian","orcid":"https://orcid.org/0000-0001-8273-0813","observed_orcids":["https://orcid.org/0000-0001-8273-0813"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I2801317318","display_name":"Hospital for Sick Children","ror":"https://ror.org/057q4rt57","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801317318"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Gholamreza Ahmadian","raw_affiliation_strings":["Brain and Behavior Program, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada M5G 1X8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brain and Behavior Program, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada M5G 1X8","institution_ids":["https://openalex.org/I185261750","https://openalex.org/I2801317318"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041640413","display_name":"Chun Che Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I2801317318","display_name":"Hospital for Sick Children","ror":"https://ror.org/057q4rt57","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801317318"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Chun Che Liu","raw_affiliation_strings":["Brain and Behavior Program, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada M5G 1X8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brain and Behavior Program, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada M5G 1X8","institution_ids":["https://openalex.org/I185261750","https://openalex.org/I2801317318"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047476496","display_name":"Yu Tian Wang","orcid":"https://orcid.org/0000-0001-8592-0698","observed_orcids":["https://orcid.org/0000-0001-8592-0698"]},"institutions":[{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Yu Tian Wang","raw_affiliation_strings":["Brain Research Centre, University of British Columbia, Vancouver, BC, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brain Research Centre, University of British Columbia, Vancouver, BC, Canada","institution_ids":["https://openalex.org/I141945490"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019797356","display_name":"K. Michael Gibson","orcid":"https://orcid.org/0000-0003-4465-1318","observed_orcids":["https://orcid.org/0000-0003-4465-1318"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K.Michael Gibson","raw_affiliation_strings":["Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR, USA","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000338259","display_name":"Andrew R. Calver","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andrew R. Calver","raw_affiliation_strings":["GlaxoSmithKline, Neurology, and GI CEDD, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Neurology, and GI CEDD, Harlow, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074055562","display_name":"Joseph Francis","orcid":"https://orcid.org/0000-0002-9502-4579","observed_orcids":["https://orcid.org/0000-0002-9502-4579"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I2801317318","display_name":"Hospital for Sick Children","ror":"https://ror.org/057q4rt57","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801317318"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Joseph Francis","raw_affiliation_strings":["Brain and Behavior Program, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada M5G 1X8","Division of Neurology, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brain and Behavior Program, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada M5G 1X8","institution_ids":["https://openalex.org/I185261750","https://openalex.org/I2801317318"]},{"raw_affiliation_string":"Division of Neurology, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada","institution_ids":["https://openalex.org/I185261750","https://openalex.org/I2801317318"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010982846","display_name":"Menelas N. Pangalos","orcid":"https://orcid.org/0000-0001-9783-0956","observed_orcids":["https://orcid.org/0000-0001-9783-0956"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Menelas N. Pangalos","raw_affiliation_strings":["GlaxoSmithKline, Neurology, and GI CEDD, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Neurology, and GI CEDD, Harlow, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015390605","display_name":"O. Carter Snead","orcid":"https://orcid.org/0000-0001-8910-0478","observed_orcids":["https://orcid.org/0000-0001-8910-0478"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I2801317318","display_name":"Hospital for Sick Children","ror":"https://ror.org/057q4rt57","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801317318"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"O. Carter Snead","raw_affiliation_strings":["Brain and Behavior Program, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada M5G 1X8","Department of Pediatrics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada","Division of Neurology, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brain and Behavior Program, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada M5G 1X8","institution_ids":["https://openalex.org/I185261750","https://openalex.org/I2801317318"]},{"raw_affiliation_string":"Department of Pediatrics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"Division of Neurology, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada","institution_ids":["https://openalex.org/I185261750","https://openalex.org/I2801317318"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5015390605"],"corresponding_institution_ids":["https://openalex.org/I185261750","https://openalex.org/I2801317318"],"apc_list":{"value":4300,"currency":"USD","value_usd":4300},"apc_paid":null,"fwci":2.2816,"has_fulltext":false,"cited_by_count":61,"citation_normalized_percentile":{"value":0.87208762,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"47","issue":"8","first_page":"1146","last_page":"1156"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9448000192642212,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9448000192642212,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.04699999839067459,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gamma-hydroxybutyric-acid","display_name":"gamma-hydroxybutyric acid","score":0.9900000095367432},{"id":"https://openalex.org/keywords/ghb-receptor","display_name":"GHB receptor","score":0.7129999995231628},{"id":"https://openalex.org/keywords/gabab-receptors","display_name":"GABAB receptors","score":0.8920000195503235},{"id":"https://openalex.org/keywords/receptor-binding-sites","display_name":"receptor binding sites","score":0.6909999847412109},{"id":"https://openalex.org/keywords/ncs-382","display_name":"NCS-382","score":0.8289999961853027}],"concepts":[{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.6541774868965149},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.6407693028450012},{"id":"https://openalex.org/C174510640","wikidata":"https://www.wikidata.org/wiki/Q489618","display_name":"HEK 293 cells","level":3,"score":0.6200256943702698},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.6042867302894592},{"id":"https://openalex.org/C101027131","wikidata":"https://www.wikidata.org/wiki/Q305671","display_name":"GABAB receptor","level":4,"score":0.5258068442344666},{"id":"https://openalex.org/C168258287","wikidata":"https://www.wikidata.org/wiki/Q60147","display_name":"GABAA receptor","level":3,"score":0.49279287457466125},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4859553575515747},{"id":"https://openalex.org/C2777771985","wikidata":"https://www.wikidata.org/wiki/Q210021","display_name":"gamma-Aminobutyric acid","level":3,"score":0.4296186566352844},{"id":"https://openalex.org/C2779414652","wikidata":"https://www.wikidata.org/wiki/Q3604505","display_name":"Aminobutyric acid","level":3,"score":0.41636601090431213},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3750743269920349},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3745594620704651},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3253580927848816}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001665","descriptor_name":"Binding Sites","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011956","descriptor_name":"Receptors, Cell Surface","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D011956","descriptor_name":"Receptors, Cell Surface","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D012978","descriptor_name":"Sodium Oxybate","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018080","descriptor_name":"Receptors, GABA-B","qualifier_ui":"Q000172","qualifier_name":"deficiency","is_major_topic":false},{"descriptor_ui":"D018080","descriptor_name":"Receptors, GABA-B","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D018080","descriptor_name":"Receptors, GABA-B","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018345","descriptor_name":"Mice, Knockout","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.neuropharm.2004.08.019","doi":"https://doi.org/10.1016/j.neuropharm.2004.08.019","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.neuropharm.2004.08.019","pdf_url":null,"source":{"id":"https://openalex.org/S160566677","display_name":"Neuropharmacology","issn_l":"0028-3908","issn":["0028-3908","1873-7064"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropharmacology","raw_type":"journal-article"},{"id":"pmid:15567424","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15567424","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropharmacology","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[{"id":"https://openalex.org/G2018252243","display_name":"Murine Knockout Model of 4-Hydroxybutyric Aciduria","funder_award_id":"R01NS040270","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"}],"funders":[{"id":"https://openalex.org/F4320337359","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W1654156243","https://openalex.org/W1906557722","https://openalex.org/W1986584374","https://openalex.org/W1996412351","https://openalex.org/W2007446383","https://openalex.org/W2007889607","https://openalex.org/W2008345349","https://openalex.org/W2016897045","https://openalex.org/W2026968086","https://openalex.org/W2032310869","https://openalex.org/W2047149185","https://openalex.org/W2060490717","https://openalex.org/W2062253725","https://openalex.org/W2068134115","https://openalex.org/W2072863696","https://openalex.org/W2075720494","https://openalex.org/W2076528772","https://openalex.org/W2079128423","https://openalex.org/W2079128619","https://openalex.org/W2079475128","https://openalex.org/W2083251993","https://openalex.org/W2090278597","https://openalex.org/W2095564883","https://openalex.org/W2101598476","https://openalex.org/W2121297747","https://openalex.org/W2124517960","https://openalex.org/W2130262301","https://openalex.org/W2133542906","https://openalex.org/W2139578829","https://openalex.org/W2144985457","https://openalex.org/W2156277612","https://openalex.org/W2157909194","https://openalex.org/W2163874819","https://openalex.org/W2165696259","https://openalex.org/W2172001944","https://openalex.org/W2216923479","https://openalex.org/W2476751078","https://openalex.org/W2499316476","https://openalex.org/W4406054929","https://openalex.org/W4406065802","https://openalex.org/W6677393112"],"related_works":["https://openalex.org/W2172001944","https://openalex.org/W2157909194","https://openalex.org/W2016167852","https://openalex.org/W2041909724","https://openalex.org/W2073633272","https://openalex.org/W2007446383","https://openalex.org/W2097117220","https://openalex.org/W2038704240","https://openalex.org/W1975172138","https://openalex.org/W2032943446"],"abstract_inverted_index":null,"counts_by_year":[{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}